Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Current Taxes (2022 - 2026)

Sunshine Biopharma filings provide 4 years of Current Taxes readings, the most recent being $268276.0 for Q4 2025.

  • On a quarterly basis, Current Taxes changed 0.0% to $268276.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $268276.0, a 0.0% change, with the full-year FY2025 number at $268276.0, changed 0.0% from a year prior.
  • Current Taxes hit $268276.0 in Q4 2025 for Sunshine Biopharma, up from $258158.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $416245.0 in Q1 2023 to a low of $201541.0 in Q3 2023.
  • Median Current Taxes over the past 4 years was $256564.5 (2024), compared with a mean of $275763.8.
  • The widest YoY moves for Current Taxes: up 26.51% in 2024, down 38.74% in 2024.
  • Sunshine Biopharma's Current Taxes stood at $373191.0 in 2022, then fell by 19.65% to $299869.0 in 2023, then decreased by 10.54% to $268276.0 in 2024, then changed by 0.0% to $268276.0 in 2025.
  • The last three reported values for Current Taxes were $268276.0 (Q4 2025), $258158.0 (Q2 2025), and $228115.0 (Q1 2025) per Business Quant data.